InSimu: InSimu, an EdTech startup based in Hungary, was founded in 2016. The company's slogan, "Interactive patient simulation platform to reinvent medical education," reflects its focus on transforming medical learning. InSimu offers the InSimu Patient app, a diagnostic SaaS that allows medical professionals and students to practice clinical work in a safe virtual reality environment using simulated patients and a full range of diagnostic methods. This innovative approach changes the way young medical professionals learn and think, adopting a "medutainment" approach to engage and educate. Notably, InSimu provides diagnostic courses accredited for Continuing Medical Education in the U.S., such as the Differential Diagnostics of Abdominal Pain Using Virtual Patients course, which has been approved for 1.50 AAFP Elective credits. In October 2020, the company secured a €323.00K Seed Round investment from Hiventures. InSimu's ultimate goal is to improve the safety, efficiency, and accuracy of medical diagnoses worldwide. The platform aims to make medical training measurable and more efficient while enhancing student satisfaction with the quality of education. This highlights the company's potential to revolutionize medical education and upgrade diagnostic skills, making it an appealing prospect for venture capital investment.
No recent news or press coverage available for InSimu.